TATVANSETatva Chintan Pharma Chem LimitedMinimalNeutral
Announced Tue, 19 May · 14:53 IST

Ajay Mansukhlal Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

TATVA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.2%1-day move
₹1250.00
prior close
₹1290.30
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-0.5-0.4-0.8-0.2-5.3-4.8-5.2-7.1-9.8-10.7-4.4+37.1
Up moveDown movePending
AI summary

Promoter Ajay Mansukhlal Patel has submitted a declaration to BSE and NSE confirming that neither he nor any person acting in concert (PAC) created any encumbrance (pledge) on the company's shares during the financial year ending 31 March 2026. The filing lists 10 other entities in the promoter group including family members and Star Enterprise. This is a mandatory annual compliance filing under SEBI regulations for listed companies.

Likely market impact

No encumbrance on promoter shares is generally viewed positively as it signals that promoters have not leveraged their holdings, reducing risk for minority shareholders.